课题基金 / 基金详情

Vindoline and Vinblastine

Vindoline and Vinblastine
文多林和长春花碱
批准号:
7090970
负责人:
DALE L BOGER
金额:
$33.0万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-10 至 2011-02-28

项目摘要

项目成果

DALE L BOGER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Studies on the development of a diastereoselective and enantioselective total synthesis of vindoline and the clinically important antitumor drug vinblastine are detailed based on implementation of a unique tandem Diels-Alder/1,3-dipolar cycloaddition cascade of 1,3,4-oxadiazoles. In addition to defining the scope of such tandem cycloaddition cascades, applications in the total synthesis of (1) vindorosine, (2) minovine, (3) aspidospermidine, (4) (-)-vindoline, (5) (+)-vinblastine and (+)-vincristine, (6) and an extensive series of (+)-vinblastine analogues are detailed. The proposed studies include the examination of antitumor compounds that mediate their cellular effects through tubulin binding and provide a well-defined problem on the design, preparation, and evaluation of synthetic, mechanism-based analogues in which fundamental studies of the structural features responsible for tubulin binding affinity and selectivity may be addressed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulating Signaling Endocannabinoids and Fatty Acid Amides
  • 批准号:
    10532252
  • 项目类别:
  • 资助金额:
    $39.94万
  • 财政年份:
    2021
  • 负责人:
    DALE L BOGER
  • 依托单位:
Modulating Signaling Endocannabinoids and Fatty Acid Amides
  • 批准号:
    10399712
  • 项目类别:
  • 资助金额:
    $39.94万
  • 财政年份:
    2021
  • 负责人:
    DALE L BOGER
  • 依托单位:
A Unique Class of Reductively Activated Oncology Drugs
  • 批准号:
    9311686
  • 项目类别:
  • 资助金额:
    $71.9万
  • 财政年份:
    2017
  • 负责人:
    DALE L BOGER
  • 依托单位:
A Unique Class of Reductively Activated Oncology Drugs
  • 批准号:
    10116967
  • 项目类别:
  • 资助金额:
    $71.9万
  • 财政年份:
    2017
  • 负责人:
    DALE L BOGER
  • 依托单位:
海外基金